Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Climb Bio, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
CLYM (Climb Bio, Inc.) has 6 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
No intraday reading yet this session.
109 institutional managers report a position in Climb Bio, Inc. worth $735.2M between them, filed on form 13F for the quarter ending 2026-06-30. 18 of them hold 80% of it, the largest being RA Capital Management, LLC at 20.04%.
84 more managers in the register
18 managers hold 80% of the $735.2M institutional base. The other 91 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via RA Capital Management, LLC, Adage Capital Partners GP, L.L.C., Driehaus Capital Management LLC +1 more · 20.04% of CLYM, 20.52% of SION
via RA Capital Management, LLC, Cormorant Asset Management, LLC · 20.04% of CLYM, 29.22% of PBLS
via RA Capital Management, LLC, ADAR1 Capital Management, LLC, Driehaus Capital Management LLC +2 more · 20.04% of CLYM, 38.51% of PEPG
via RA Capital Management, LLC, Driehaus Capital Management LLC, Braidwell LP +2 more · 20.04% of CLYM, 21.58% of COAG
via RA Capital Management, LLC, ADAR1 Capital Management, LLC, Ikarian Capital, LLC +1 more · 20.04% of CLYM, 43.81% of ABOS
via RA Capital Management, LLC, Adage Capital Partners GP, L.L.C., Braidwell LP +7 more · 20.04% of CLYM, 7.13% of OVID
Managers holding a meaningful stake in CLYM also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.